The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Infectious Disease Molecular Diagnostics Market Between 2026 And 2030?
The infectious disease molecular diagnostics market has experienced robust expansion over recent years. Projections indicate a rise from $30.46 billion in 2025 to $32.04 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 5.2%. This historical growth can be linked to the increasing occurrence of infectious diseases, progress in PCR and sequencing technologies, augmented government investment in infectious disease research, heightened recognition of the importance of early diagnosis, and the proliferation of clinical laboratories.
The infectious disease molecular diagnostics market is anticipated to experience consistent expansion in the coming years. This market is projected to reach $38.77 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.9%. Several factors contribute to this growth during the forecast period, including the increasing integration of AI-driven diagnostic instruments, a heightened need for quick and precise diagnostic methods, the development of healthcare infrastructure in emerging markets, a stronger emphasis on personalized medical treatments, and the proliferation of at-home molecular diagnostic products. Key trends anticipated over this period encompass the widespread use of rapid point-of-care diagnostics, an increasing requirement for multiplex testing, the incorporation of molecular diagnostics into electronic health record (EHR) systems, the broadening scope of infectious disease surveillance initiatives, and a sharpened focus on identifying antimicrobial resistance.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25793&type=smp
What Leading Drivers Are Supporting The Infectious Disease Molecular Diagnostics Market Expansion?
The increasing occurrence of infectious diseases is projected to stimulate the expansion of the infectious disease molecular diagnostics market. These diseases are defined as illnesses resulting from pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, capable of direct or indirect transmission between individuals. The heightened prevalence of infectious diseases stems primarily from globalization and increased travel, enabling pathogens to disseminate rapidly across borders and transform localized outbreaks into global health emergencies. Infectious disease molecular diagnostics play a crucial role in managing these conditions by facilitating the swift and accurate detection of pathogens at the genetic level, which in turn supports early diagnosis, targeted therapeutic approaches, and effective containment of outbreaks. For instance, in November 2024, the US Centers for Disease Control and Prevention (CDC), a US-based government agency, stated that tuberculosis (TB) cases in 2023 reached 9,633, an increase from 8,332 in 2022, representing a 15.6% rise in the case count. Thus, the escalating prevalence of infectious diseases is a key factor driving the growth of the infectious disease molecular diagnostics market.
What Are The Key Segment Divisions In The Infectious Disease Molecular Diagnostics Market Segment Structure?
The infectious disease molecular diagnostics market covered in this report is segmented –
1) By Product Type: Kits And Reagents, Instruments, Software And Services
2) By Technology: Polymerase Chain Reaction, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology, Chips And Microarrays, Sequencing-Based Molecular Diagnostics, Transcription Mediated Amplification, Other Technologies
3) By Application: Respiratory Diseases, Tuberculosis, Meningitis, Gastrointestinal Tract Infections, Human Papillomavirus, Sexually Transmitted Infections, Sepsis, Drug Resistance Diseases, Other Applications
4) By End-User: Hospitals And Clinical Laboratories, Diagnostic Laboratories, Pharmaceutical Companies, Academic And Research Institutes
Subsegments:
1) By Kits And Reagents: Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Isothermal Amplification Kits, Probe-Based Detection Reagents, Pathogen-Specific Assay Kits
2) By Instruments: Real-Time Polymerase Chain Reaction Systems, Isothermal Amplification Instruments, Automated Sample Preparation Systems, Next-Generation Sequencing Platforms, Microarray Analyzers
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information Management Systems, Cloud-Based Infectious Disease Diagnostic Platforms, Instrument Integration And Workflow Management Tools, Bioinformatics Services
What Emerging Trends Are Seen In The Infectious Disease Molecular Diagnostics Market?
Major corporations within the infectious disease molecular diagnostics sector are concentrating their efforts on creating advanced solutions, such as real-time polymerase chain reaction kits, to facilitate swift, precise, and high-volume identification of infectious pathogens. Real-time polymerase chain reaction (PCR) kits serve as diagnostic instruments that magnify and concurrently identify particular genetic material from pathogens instantly, thus allowing for the quick and accurate diagnosis of infectious illnesses. For example, in February 2023, Thermo Fisher Scientific Inc., a US-based biotechnology and life sciences firm, introduced its Applied Biosystems TaqPath polymerase chain reaction kits in India, designed for detecting infectious diseases. These kits represent rapid, highly sensitive multiplex diagnostic options that enable real-time polymerase chain reaction detection of infectious disease targets through a comprehensive process, from ribonucleic acid extraction to the generation of a diagnostic report, typically completed in under 4 hours. These solutions incorporate multiplexed assays aimed at various genomic regions of pathogens, include integrated process controls, and offer automated data analysis, thereby minimizing user mistakes and improving the dependability of results.
Which Organizations Are Engaged In The Infectious Disease Molecular Diagnostics Market?
Major companies operating in the infectious disease molecular diagnostics market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company (BD), Agilent Technologies Inc., Hologic Inc., Illumina Inc., Biomerieux S.A., Quidel-Ortho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Seegene Inc., Oxford Nanopore Technologies plc, Biocartis NV, T2 Biosystems Inc., Sherlock Biosciences Inc.
Get The Full Infectious Disease Molecular Diagnostics Market Report:
Which Region Is The Leading Market For The Infectious Disease Molecular Diagnostics Market?
North America was the largest region in the infectious disease molecular diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Infectious Disease Molecular Diagnostics Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=25793&type=smp
Browse Through More Reports Similar to the Global Infectious Disease Molecular Diagnostics Market 2026, By The Business Research Company
Infection Control Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-control-global-market-report
Infection Prevention Market Report 2026
https://www.thebusinessresearchcompany.com/report/infection-prevention-global-market-report
Hospital Acquired Infection Control Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model